Biosimilars Blog
RF 360
Brett A. Postal Associate

Brett A. Postal has a wide range of experience across many different areas of patent law including patent litigation, patent prosecution, opinion work, and counseling.  Mr. Postal has worked on a variety of litigation matters in district courts throughout the United States with a special focus on Hatch-Waxman litigation.  Mr. Postal also has experience working on Patent Trial and Appeal Board proceedings and Section 337 matters before the International Trade Commission.  In 2014, 2017, and 2018, Mr. Postal was named a Rising Star by Washington D.C. Super Lawyers.

Mr. Postal’s practice involves many different technical fields including the chemical, biological, pharmaceutical, computer science, and mechanical engineering arts.  While Mr. Postal has worked with many different technologies, he specializes on the chemical and pharmaceutical arts and has familiarity working on pharmaceutical products, polymers and resins, liquid crystal technology, photovoltaic devices, semiconductors, inorganic glasses, and chemical coatings.

Mr. Postal first joined Rothwell Figg as a summer associate and continued to work with the firm as a law clerk while attending law school.  After graduating from The George Washington University Law School with honors, Mr. Postal joined the firm as a full time associate. During law school, Mr. Postal was a Member and Note Editor of The American Intellectual Property Law Association Quarterly Journal, a Member of The George Washington University Law School Moot Court Board, and a Dean’s Fellow and Writing Fellow in The George Washington University Law School’s legal writing and research program.

In 2008, Mr. Postal graduated magna cum laude from the University of Pittsburgh with a Bachelor of Science degree in Chemistry and a Bachelor of Arts degree in Philosophy. While an undergraduate student, Mr. Postal worked in the research laboratory of Dr. Amy Wagner conducting research on neurochemical biomarkers.


Cipher Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.
United States District Court for the District of New Jersey

Unverferth Manufacturing Co., Inc. v. Par-Kan Co.
United States District Court for the Northern District of Indiana

Sunovion Pharmaceutical. Inc. v. Watson Pharmaceuticals Inc.
United States District Court for the District of Delaware

Mylan Pharmaceuticals, Inc. v. Sebelius
United States District Court for the District of Columbia

Cephalon, Inc. v. Mylan Pharmaceuticals Inc.
United States District Court for the District of Delaware

Novartis Pharmaceuticals Corporation v. Watson Laboratories, Inc.
United States District Court for the District of Delaware

In re Lithium Silicate Materials and Products Containing the Same
International Trade Commission

Publications & Presentations

Wagner AK, Amin KB, Niyonkuru C, Postal BA, McCullough EH, Ozawa H, Dixon CE, Bayir H, Clark RS, Kochanek PM, and Fabio A., CSF Bcl-2 and Cytochrome C Temporal Profiles in Outcome Prediction for Adults with Severe TBI, Journal of Cerebral Blood Flow & Metabolism (2011) 31, 1886-1896.

Wagner AK, Postal BA, Darrah SD, Chen X, Khan AS, Deficits in Novelty Exploration After Controlled Cortical Impact, Journal of Neurotrauma (2007) 8, 1308-20. 


Professional Affiliations, Honors & Recognition

Washington, DC Super Lawyers "Rising Star" (2017-2018)